Inovio Pharma (INO) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.22 +2.52%
EPS Growth %: +60.7%
Financial Fact:
General and administrative: 5.76M
Today's EPS Names:
More
EPS Growth %: +60.7%
Financial Fact:
General and administrative: 5.76M
Today's EPS Names:
More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q4 EPS of ($0.12), $0.02 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $5.24 million.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- SAS CEO van der Werff emerges as frontrunner for Air Canada top job - Bloomberg
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
